Juno Lighting, Inc. JUNO
86.96 0.00 (+0.00%)
At closeJun 28, 2019, 6:07 PM EDT
86.96 Day range 86.96
85.47 52-week range 85.77
News
prnewswire.com Seren Juno and Ribbon Achieve 20Tbps Transmission on 10,000 km JUNO Trans-Pacific Cable PLANO, Texas , Nov. 12, 2025 /PRNewswire/ -- Ribbon Communications Inc. (Nasdaq: RBBN), a global leader in real-time communications technology and IP optical networking solutions, today announced the…
businesswire.com NTT DATA-led JUNO Submarine Cable Plans to Deploy Ciena's WaveLogic 6 to Boost Network Capacity TOKYO--(BUSINESS WIRE)--Seren Juno Network Co., Ltd. and Seren Juno Network America Inc (Seren), operator of the NTT DATA-led JUNO submarine cable system, will deploy Ciena's (NYSE: CIEN) GeoMesh…
https://www.marketscreener.com Britain's Royal Mint launches coin for 80th anniversary of D-Day landings LONDON (Reuters) - Britain's Royal Mint has launched a coin marking next month's 80th anniversary of the 1944 D-Day landings, when 150,000 Allied soldiers invaded France to drive out the forces of…
businesswire.com Juno Therapeutics to Report Third Quarter 2017 Financial Results on
Wednesday, November 1 SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the third quarter 2017 on Wednesday, November 1, 2017, after the close of U.S.-based financial…
businesswire.com Juno Therapeutics to Report Second Quarter 2017 Financial Results on
Thursday, August 3 SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the second quarter 2017 on Thursday, August 3, 2017, after the close of U.S.-based financial…
businesswire.com Juno Therapeutics to Report First Quarter 2017 Financial Results on
Thursday, May 4 SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the first quarter 2017 on Thursday, May 4, 2017, after the close of U.S.-based financial markets.…
benzinga.com Freeport-McMoRan, Juno Therapeutics, Square And European Banks: Fast Money Picks For April 26 
businesswire.com Juno Therapeutics to Report Full Year and Fourth Quarter 2016
Financial Results on Wednesday, March 1 SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ:JUNO) will announce financial results for the fourth quarter and year ended December 31, 2016, on Wednesday, March 1, 2017, after the close…
businesswire.com Juno Therapeutics Places JCAR015 Phase II ROCKET Trial on Clinical
Hold SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (Nasdaq: JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced…
businesswire.com Juno Therapeutics to Report Third Quarter 2016 Financial Results on
Wednesday, November 9 SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ:JUNO) will announce financial results for the third quarter 2016 on Wednesday, November 9, 2016, after the close of U.S.-based financial…
businesswire.com Juno Therapeutics to Report Second Quarter 2016 Financial Results on
Thursday, August 4 SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the second quarter 2016 on Thursday, August 4, 2016, after the close of U.S.-based financial…
businesswire.com Juno Therapeutics Reports Clinical Hold on the JCAR015 Phase II
ROCKET Trial SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced…
benzinga.com 12 Stocks Moving In Wednesday's Pre-Market Session 
businesswire.com Juno Therapeutics to Report First Quarter 2016 Financial Results on
Monday, May 9 SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the first quarter 2016 on Monday, May 9, 2016, after the close of U.S.-based financial markets.…
businesswire.com Juno Therapeutics to Report Full Year and Fourth Quarter 2015
Financial Results on Monday, February 29 SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ: JUNO) will announce financial results for the fourth quarter and year ended December 31, 2015 on Monday, February 29, 2016, after the close…- benzinga.com Benzinga's Top Upgrades
businesswire.com Juno Therapeutics to Report Third Quarter 2015 Financial Results on
Tuesday, November 10 SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (NASDAQ:JUNO) will announce financial results for the third quarter of 2015 on Tuesday, November 10, 2015, after the close of U.S.-based financial…
benzinga.com Dyax, Juno Therapeutics Soar Following Biotech Index Rebalance